文献速递糖尿病

持续葡萄糖监测与接受透析的糖尿病退伍军人死亡风险关联

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes.
PubMed 文献 · Diabetes Care · 2026-01-01

本研究基于美国退伍军人事务部、美国肾脏数据系统及Medicare关联数据,纳入2012年1月至2023年12月新处方CGM的透析合并糖尿病患者,按倾向评分匹配非CGM使用者,随访全因死亡至2025年2月。完全病例分析队列2008例中,CGM使用与较低死亡风险相关(双重调整HR 0.83,95%CI 0.75-0.92);多重插补队列3088例结果一致(HR 0.84,95%CI 0.73-0.96)。

要点

  • 透析合并糖尿病患者中新使用CGM与更低的全因死亡风险相关。
  • 完全病例分析与多重插补分析结果一致,支持关联稳健性。
  • 机制及CGM对其他透析结局的影响尚需进一步研究。

核心结论

  • 在接受透析的糖尿病退伍军人中,新使用CGM相比非CGM使用与更好的生存相关。

研究设计与样本

  • 研究利用美国退伍军人事务部、美国肾脏数据系统及Medicare关联数据,纳入2012年1月至2023年12月新处方CGM的透析合并糖尿病患者,按倾向评分匹配非CGM使用者,随访全因死亡至2025年2月。
  • 完全病例分析队列2008例,多重插补队列3088例。

主要发现

  • 完全病例分析队列中,倾向评分匹配未调整Cox模型HR 0.86(95%CI 0.76-0.98),双重调整模型HR 0.83(95%CI 0.75-0.92)。
  • 多重插补队列中,倾向评分匹配未调整Cox模型HR 0.88(95%CI 0.77-0.99),双重调整模型HR 0.84(95%CI 0.73-0.96)。

临床怎么用

  • 对于接受透析的糖尿病患者,可考虑使用CGM以辅助血糖管理并可能改善生存,但需结合个体情况。

局限性

  • 研究为观察性设计,可能存在残余混杂。
  • 机制尚未明确,且CGM对其他透析结局的影响未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients receiving dialysis who have diabetes have a high burden of dysglycemia. Whereas traditional glycemic markers have limited accuracy and convenience in dialysis, continuous glucose monitoring (CGM) provides automated, less invasive, and more comprehensive glycemic data than do conventional measures. However, it remains unclear whether CGM is associated with improved clinical outcomes in patients undergoing dialysis. RESEARCH DESIGN AND METHODS: We examined the association between CGM use versus non-CGM use and survival among U.S. veterans receiving dialysis who also have diabetes, using linked national Veterans Affairs, U.S. Renal Data System, and Medicare data. We examined data from veterans undergoing dialysis and with diabetes with incident CGM use (newly prescribed CGM) versus non-CGM use over the period January 2012 to December 2023 matched by propensity score (PS) to address confounding by indication and who were followed for all-cause mortality events through February 2025. Associations of CGM use versus non-CGM use with death were evaluated using complete case analysis and multiple imputation. RESULTS: Among 2,008 patients in the complete case analysis cohort, CGM use was associated with a lower mortality risk in PS-matched unadjusted and doubly adjusted Cox models (reference: non-CGM use; hazard ratio [HR] 0.86 [95% CI 0.76, 0.98]; and 0.83 [95% CI 0.75, 0.92], respectively). Among 3,088 patients in the multiple imputation cohort, CGM use was also associated with greater survival in PS-matched unadjusted and doubly adjusted Cox models (HR 0.88 [95% CI 0.77, 0.99]; and 0.84 [95% CI 0.73, 0.96], respectively). CONCLUSIONS: In veterans receiving dialysis who also had diabetes, incident CGM use was associated with better survival versus non-CGM use. Further studies are needed to determine underlying mechanisms and the impact of CGM on other dialysis outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Narasaki Y, Kalantar-Zadeh K, Zisman-Ilani Y, et al. Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes. Diabetes Care. 2026. PMID: 42224118. doi:10.2337/dc26-0004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。